These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3185363)

  • 1. Marginal analysis applied to the dose-response curve.
    Silber JH; Kaizer H
    Med Pediatr Oncol; 1988; 16(5):344-8. PubMed ID: 3185363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoresponsiveness of Moloney sarcoma virus-induced osteosarcoma to adriamycin in the rat.
    Olson HM; Capen CC
    Cancer Res; 1978 Jun; 38(6):1561-7. PubMed ID: 274173
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiomyopathy after osteosarcoma treatment: a contribution to the cardiotoxicity of adriamycin].
    Geidel S; Garn M; Grävinghoff L; Hausdorf G; Morf G; Bielack S; Knop J; Winkler K
    Klin Padiatr; 1991; 203(4):257-61. PubMed ID: 1942931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripartum heart failure in a patient treated previously with doxorubicin.
    Davis LE; Brown CE
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):506-8. PubMed ID: 3162299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug chemotherapy in osteosarcoma.
    Sutow WW
    Clin Orthop Relat Res; 1980; (153):67-72. PubMed ID: 7004713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
    Levine AS; Appelbaum FR; Graw RG; Magrath IT; Pizzo PA; Poplack DG; Ziegler JL
    Cancer Treat Rep; 1978 Feb; 62(2):247-50. PubMed ID: 346213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
    Cohen IJ
    Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of adjuvant chemotherapy in osteogenic osteosarcoma: comparison of altering sequential administrations of high doses of adriamycin, methotrexate, and cyclophosphamide with a 6-month administration of high-dose adriamycin followed by a low-dose semicontinuous chemotherapy. EORTC Osteosarcoma Working Party Group.
    Recent Results Cancer Res; 1978; 68():28-32. PubMed ID: 288108
    [No Abstract]   [Full Text] [Related]  

  • 9. Doxorubicin in disseminated osteosarcoma.
    Cores EP; Holland JF; Wang JJ; Sinks LF
    JAMA; 1972 Sep; 221(10):1132-8. PubMed ID: 4512088
    [No Abstract]   [Full Text] [Related]  

  • 10. [Congestive cardiomyopathy after doxorubicin (adriamycin)author's transl)].
    Kaduk B; Seiler G
    Dtsch Med Wochenschr; 1977 Dec; 102(49):1813-7. PubMed ID: 271071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
    Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
    Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
    Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H
    J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of corrected QT interval in the cardiologic follow-up of young patients treated with Adriamycin.
    Ferrari S; Figus E; Cagnano R; Iantorno D; Bacci G
    J Chemother; 1996 Jun; 8(3):232-6. PubMed ID: 8808723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Received dose and dose-intensity of chemotherapy and outcome in nonmetastatic extremity osteosarcoma. European Osteosarcoma Intergroup.
    Lewis IJ; Weeden S; Machin D; Stark D; Craft AW
    J Clin Oncol; 2000 Dec; 18(24):4028-37. PubMed ID: 11118463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant chemotherapy of osteosarcoma].
    Yamawaki S; Isu K; Ubayama Y; Takeda N; Yagi T; Usui M; Isii S
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):180-8. PubMed ID: 2301948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
    Yu W; Tang L; Lin F; Yao Y; Shen Z
    Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma.
    Longhi A; Ferrari S; Bacci G; Specchia S
    Anticancer Drugs; 2007 Jul; 18(6):737-44. PubMed ID: 17762406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
    Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
    Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
    Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
    Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.